Target intelligence / Profile preview

Novel transcript, antisense to SBNO2

Molecular classification: Other (non-coding RNA)

Overview

This is a novel transcript and is antisense to the gene SBNO2 (Strawberry notch homolog 2)[3]. It is classified as a non-coding RNA and likely plays a regulatory role at the transcriptional or post-transcriptional level, possibly modulating expression of the adjacent SBNO2 gene. There is currently no evidence that it serves as a protein-coding gene, receptor, enzyme, or therapeutic target, and there are no data supporting druggability or involvement in disease processes as a stand-alone molecular target[3].

Biological functions

Other (antisense regulation)

Disease associations

Other (potential regulatory RNA)

Beyond the preview

Go deeper on Novel transcript, antisense to SBNO2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to SBNO2.

Explore the full profile